AstraZeneca begins European exit — will invest $50 billion in the U.S. amid tariff threats
British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington. A large chunk of the funds…






